首页|羟考酮复合右美托咪定对甲状腺腔镜手术患者全身麻醉气管插管应激反应的影响

羟考酮复合右美托咪定对甲状腺腔镜手术患者全身麻醉气管插管应激反应的影响

扫码查看
目的 比较羟考酮复合右美托咪定与舒芬太尼复合右美托咪定在甲状腺腔镜手术全身麻醉气管插管时对患者应激反应的影响.方法 选取杭州市第一人民医院2022年2月至2024年2月收治的84例行甲状腺腔镜手术患者,按随机数字表法分为两组,每组42例.两组患者均先给予右美托咪定0.5 μg·kg-1,对照组使用舒芬太尼0.3 μg·kg-1静脉输注,观察组使用羟考酮0.2 mg·kg-1静脉输注.对比两组患者一般资料、不同时间点[麻醉前(T0)、插管时(T1)、插管后1 min(T2)、插管后5 min(T3)]生命体征指标[心率(HR)、平均动脉压(MAP)]、不同时间点应激指标[血浆肾上腺素(E)和去甲肾上腺素(NE)]、用药后及插管期间不良反应发生情况.结果 在T1时间点,对照组和观察组患者的HR[分别为(53.08±6.24)次·min-1、(65.13±7.32)次·min-1]、MAP[分别为[(77.62±8.27)mm Hg、(78.31±9.35)mm Hg(1 mm Hg≈0.133 kPa)]均低于T0时间的HR[分别为(74.72±10.51)次·min-1、(76.61±9.62)次·min-1]、MAP[分别为(93.25±8.57)mm Hg、(94.87±10.59)mm Hg],且T1时间点对照组HR低于观察组(P<0.05);在T2时间点,对照组和观察组患者HR[分别为(92.48±9.51)次·min-1、(71.64±7.49)次·min-1]、MAP[分别为(105.67±7.82)mm Hg、(96.18±10.04)mm Hg]均上升;在T3时间点,对照组和观察组患者HR[分别为(87.92±8.16)次·min-1、(74.27±7.56)次·min-1]、MAP[分别为(101.46±8.97)mm Hg、(97.53±9.42)mm Hg]均上升,且对照组HR、MAP均高于观察组(均P<0.05).与T0时间点比较,对照组和观察组患者E、NE浓度在T1[分别为(37.08±6.24)ng·mL-1、(427.62±74.27)pg·mL-1、(32.16±7.32)ng·mL-1、(384.31±70.35)pg·mL-1]、T2[分别为(36.48±7.51)ng·mL-1、(421.67±60.82)pg·mL-1、(31.64±6.49)ng·mL-1、(373.18±65.04)pg·mL-1]、T3时间点[分别为(34.62±6.47)ng·mL-1、(397.46±58.97)pg·mL-1、(29.47±7.12)ng·mL-1、(361.53±51.42)pg·mL-1]均高于T0时间[分别为(24.92±4.51)ng·mL-1、(327.25±60.57)pg·mL-1、(25.31±4.62)ng·mL-1、(329.87±61.59)pg·mL-1],且对照组E、NE浓度均高于观察组(均P<0.05).在不良反应总发生率方面,观察组低血压、心动过缓、呛咳不良反应发生率[分别为7.14%(3/42)、4.76%(2/42)、2.38%(1/42)]低于对照组[分别为28.57%(12/42)、21.43%(9/42)、19.05%(8/42)](均P<0.05);对照组患者高血压、心动过速、SpO2<90%不良反应发生率[分别为4.76%(2/42)、9.52%(4/42)、4.76%(2/42)]与观察组[分别为0(0/42)、2.38%(1/42)、0(0/42)]比较差异无统计学意义(均P>0.05).结论 羟考酮复合右美托咪定用于甲状腺腔镜手术患者全身麻醉插管前诱导麻醉效果较好,可稳定血流动力学,减轻全身麻醉插管应激反应,且安全性高.
Effect of oxycodone combined with dexmedetomidine on stress response of general anesthesia for intubation in patients undergoing endoscopic thyroid surgery
Objective To compare the effect of hydrocodone combined with dexmedetomidine with that of sufentanil com-bined with dexmedetomidine on patient stress response during general anesthesia for intubation in thyroid endoscopy surgery.Methods A total of 84 patients who underwent thyroid endoscopy surgery in Hangzhou First People's Hospital from February 2022 to February 2024 were selected as the research subjects and divided into the observation group and control group using a random num-ber table method,with 42 in each group.All the patients in both groups were firstly given dexmedetomidine at a dose of 0.5 μg·kg-1.The patients in the control group received sufentanil 0.3 μg·kg-1 via intravenous infusion and those in the observation group received hy-drocodone 0.2 mg·kg-1 via intravenous infusion.The general data,physical indicators(heart rate(HR),mean arterial pressure(MAP)),stress indicators(plasma adrenaline(E)and norepinephrine(NE))concentrations,and adverse reactions at different time points(before anesthesia(T0),during intubation(T1),1 minute after intubation(T2),and 5 minutes after intubation(T3))were compared between the two groups.Results At the T1 time point,the HR and MAP were(53.08±6.24)times·min-1 and(65.13±7.32)times·min-1 in the con-trol group and(77.62±8.27)mm Hg and(78.31±9.35)mm Hg(1 mm Hg≈0.133 kPa)in the observation group.At the T0 time point,the HR of the control group was lower than that of the observation group((74.72±10.51)times·min-1 vs(76.61±9.62)times·min-1)and the MAP was(93.25±8.57)mm Hg and(94.87±10.59)mm Hg,respectively.The HR of the control group was lower than that of the ob-servation group(P<0.05).At the T2 time point,the HR was(92.48±9.51)times·min-1 and(71.64±7.49)times·min-1 while MAP was(105.67±7.82)mm Hg and(96.18±10.04)mm Hg in the control group and the observation group,demonstrating increase.At the T3 time point,the HR was(87.92±8.16)times·min-1 and(74.27±7.56)times·min-1 while MAP was(101.46±8.97)mm Hg,(97.53±9.42)mm Hg in the control group and observation group,showing increase.Meanwhile,they were significantly higher in the control group than in the observation group(all P<0.05).At the T0 time point,the concentrations of E and NE in the control group and study group were(24.92±4.51)ng·mL-1,(327.25±60.57)pg·mL-1,(25.31±4.62)ng·mL-1,(329.87±61.59)pg·mL-1.They were(37.08±6.24)ng·mL-1,(427.62±74.27)pg·mL-1,(32.16±7.32)ng·mL-1,(384.31±70.35)pg·mL-1 at the T1 time point,(36.48±7.51)ng·mL-1,(421.67±60.82)pg·mL-1,(31.64±6.49)n·mL-1,(373.18±65.04)pg·mL-1 at the T2 time point and(34.62±6.47)ng·mL-1,(397.46±58.97)pg·mL-1,(29.47±7.12)ng·mL-1,(361.53±51.42)pg·mL-1 at the T3 time point.They were all higher at T1,T2 and T3 time point than those at T0 time point.Meanwhile,they were significantly higher in the control group than in the observation group(all P<0.05).The inci-dence of adverse reactions including hypertension,tachycardia and SpO2<90%in the control group was 4.76%(2/42),9.52%(4/42)and 4.76%(2/42)and it was not significantly different from that of 0.00%(0/42),2.38%(1/42)and 0.00%(0/42)in the observation group(all P>0.05).Conclusion Oxycodone combined with dexmedetomidine is effective in inducing anesthesia before general anesthesia for intubation in pa-tients undergoing endoscopic thyroid surgery.It can stabilize the hemodynamic indexes of patients and reduce the stress response of patients undergoing general anesthesia for intubation.Furthermore,it is safe and worthy of clinical application.

OxycodoneDexmedetomidineTracheal intubationEndoscopic thyroid surgeryStress response

杨岳、彭俊波、韩锋

展开 >

杭州市第一人民医院城北院区麻醉科,杭州 310000

羟考酮 右美托咪定 气管插管 甲状腺腔镜手术 应激反应

2024

中国药物应用与监测
中国人民解放军总医院

中国药物应用与监测

CSTPCD
影响因子:1.983
ISSN:1672-8157
年,卷(期):2024.21(5)